Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions.

[1]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[2]  I. Narita,et al.  High Mortality Rate of Infectious Diseases in Dialysis Patients: A Comparison With the General Population in Japan , 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[3]  H. Kanai,et al.  15-Year Patency and Life Expectancy After Primary Stenting Guided by Intravascular Ultrasound for Iliac Artery Lesions in Peripheral Arterial Disease. , 2015, JACC. Cardiovascular interventions.

[4]  E. Wahlberg,et al.  The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  D. Scheinert,et al.  Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. , 2013, JACC. Cardiovascular interventions.

[6]  A. Ajibade,et al.  Indications and complications of major limb amputations in Kano, Nigeria. , 2013, Ghana medical journal.

[7]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  R. Chaer,et al.  Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions. , 2008, Journal of vascular surgery.

[9]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[10]  S. Muluk,et al.  Natural history of claudication: long-term serial follow-up study of 1244 claudicants. , 2001, Journal of vascular surgery.

[11]  T. Rand,et al.  Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). , 2013, Journal of the American College of Cardiology.

[12]  W. Hiatt,et al.  Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. , 2006, Journal of vascular surgery.

[13]  B. Derbel,et al.  Angioplastie de l’axe fémoro-poplité : résultats à court et à moyen terme , 2017 .

[14]  W. Gray,et al.  Long‐term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3‐year results from the STROLL study , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  M. Criqui,et al.  Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .

[16]  M. Davies.  Three-Year Outcomes of the RESILIENT Trial: Are They Enough to Support a Primary Stenting Policy? , 2012, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[17]  Zhen Wang,et al.  The natural history of untreated severe or critical limb ischemia. , 2015, Journal of vascular surgery.

[18]  S. Rajagopalan,et al.  Peripheral Arterial Disease in Patients With End-Stage Renal Disease: Observations From the Dialysis Outcomes and Practice Patterns Study (DOPPS) , 2006, Circulation.

[19]  M. Jaff,et al.  SUPERB final 3‐year outcomes using interwoven nitinol biomimetic supera stent , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[20]  Anne M Foley.  Review of article: Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery by Randall R. Martino, MD, MS, et al (J Vasc Surg 2014; 59:1615-21). , 2015, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

[21]  H. Kanai,et al.  The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. , 2010, Journal of vascular surgery.

[22]  T. Rand,et al.  Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial , 2015, CardioVascular and Interventional Radiology.

[23]  M. Makaroun,et al.  Endovascular interventions for TASC II D femoropopliteal lesions. , 2010, Journal of vascular surgery.

[24]  B. Derbel,et al.  [Femoropopliteal angioplasty: Short- and mid-term results]. , 2017, Journal de medecine vasculaire.

[25]  R. Dayal,et al.  Percutaneous Endovascular Treatment for Chronic Limb Ischemia , 2005, Annals of vascular surgery.